| 67.92 Data as of 11:12am ET |  -0.08 / -0.12%Today’s Change | 62.55 Today|||52-Week Range 76.02 | -0.61% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $2.5B |
Company Description
TECHNE Corp. is engaged in the development, manufacture and sale of biotechnology products and hematology calibrators and controls. It operates through two segments: Biotechnology and Hematology. The Biotechnology segment develops, manufactures and sells biotechnology research and diagnostic products, including proteins such as cytokines and related reagents, to the biotechnology research community. The Hematology segment develops and manufactures hematology controls and calibrators for sale world-wide. The company was founded on July 17, 1981 and is headquartered in Minneapolis, MN.
Employees
Shareholders
| Mutual fund holders | 48.32% |
| Individual stakeholders | 4.81% |
| Other institutional | 37.60% |
Top Executives
| Charles R. Kummeth, MBA | Chief Executive Officer & Director |
| Gregory J. Melsen | Chief Financial Officer, Treasurer & VP |
| Marcel Veronneau | Vice President-Hematology Operations |
| Kathleen M. Backes | Controller |
.
